Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection
1 clinical trials · Condition
◉ Watch Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection
| Record | Firm | Date |
|---|---|---|
| An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications (NCT04322188) | A.O. Ospedale Papa Giovanni XXIII | 2020-03-19 |
Track Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection automatically
Every clearance here is in the API, with alerts when new ones post.